Clinical Inquiries. How can we best treat and monitor VTE during pregnancy?
Debelak
Danielle
D
Valley Family Medicine Residency, Renton, Washington, USA.
Neher
Jon O
JO
St Anna
Leilani
L
French
Linda
L
D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D035002:Lower Extremity / Q000098:blood supply* / Q000473:pathology*; D008429:Maternal Welfare; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000628:therapy; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight